Export

You can select particular sections to be included in the output file.
EN
FR

Model List of Essential Medicines

clear Found 19 recommendations for 14 medicines and 4 therapeutic equivalents
Removed recommendations and rejected applications are shown. Hide them.
29. Medicines for diseases of joints
  1. Acetylsalicylic acid General information
    Section
    Medicines for juvenile joint diseases
    • Oral > Solid: 100 to 500 mg
    • Local > Rectal > Suppository: 50 to 150 mg
    Indications
    Acute rheumatic fever without mention of heart involvement Mucocutaneous lymph node syndrome Juvenile idiopathic arthritis
  2. Adalimumab General information
    Section
    Medicines for juvenile joint diseases
    • Parenteral > General injections > SC: 40 mg per 0.8 mL; 40 mg per 0.4 mL; 10 mg per 0.2 mL; 20 mg per 0.4 mL
    Indications
    Juvenile idiopathic arthritis
  3. Allopurinol General information
    Section
    Medicines used to treat gout
    • Oral > Solid: 100 mg
    Indications
    Gout
  4. Anakinra General information
    Section
    Medicines for juvenile joint diseases
    • Parenteral > General injections > SC: 100 mg per 0.67 mL in pre-filled syringe
    Indications
    Juvenile systemic arthritis
  5. Azathioprine General information
    Section
    Disease-modifying anti-rheumatic drugs (DMARDs)
    • Oral > Solid > tablet: 50 mg (scored)
    Indications
    Rheumatoid arthritis, serology unspecified Psoriatic arthritis
  6. Certolizumab pegol General information
    Section
    Medicines for juvenile joint diseases
    Indications
    Therapeutic equivalent to adalimumab for Juvenile idiopathic arthritis
  7. Chloroquine General information
    Section
    Disease-modifying anti-rheumatic drugs (DMARDs)
    • Oral > Solid: 100 mg tablet (as phosphate or sulfate); 150 mg tablet (as phosphate or sulfate)
    Indications
    Rheumatoid arthritis
  8. Colchicine General information
    Section
    Medicines used to treat gout
    • Oral > Solid: 0.5 mg
    Indications
    Gout
  9. Etanercept General information
    Section
    Medicines for juvenile joint diseases
    Indications
    Therapeutic equivalent to adalimumab for Juvenile idiopathic arthritis
  10. Golimumab General information
    Section
    Medicines for juvenile joint diseases
    Indications
    Therapeutic equivalent to adalimumab for Juvenile idiopathic arthritis
  11. Hydroxychloroquine General information
    Section
    Disease-modifying anti-rheumatic drugs (DMARDs)
    • Oral > Solid: 200 mg (as sulfate)
    Indications
    Systemic lupus erythematosus Cutaneous lupus erythematosus of unspecified type
  12. Infliximab General information
    Section
    Medicines for juvenile joint diseases
    Indications
    Therapeutic equivalent to adalimumab for Juvenile idiopathic arthritis
  13. Methotrexate General information
    Section
    Disease-modifying anti-rheumatic drugs (DMARDs)
    • Oral > Solid > tablet: 2.5 mg (as sodium salt)
    Indications
    Rheumatoid arthritis, serology unspecified
    Section
    Medicines for juvenile joint diseases
    • Oral > Solid > tablet: 2.5 mg (as sodium salt)
    Indications
    Juvenile idiopathic arthritis
  14. Penicillamine General information
    Section
    Disease-modifying anti-rheumatic drugs (DMARDs)
    • Oral > Solid: 250 mg
    Indications
    Rheumatoid arthritis, serology unspecified
  15. Probenecid General information
    Section
    Medicines used to treat gout
    • Oral > Solid: 500 mg
    Indications
    Gout
  16. Sulfasalazine General information
    Section
    Disease-modifying anti-rheumatic drugs (DMARDs)
    • Oral > Solid: 500 mg
    Indications
    Rheumatoid arthritis, serology unspecified
  17. Tocilizumab General information
    Section
    Medicines for juvenile joint diseases
    • Parenteral > General injections > IV: 80 mg per 4 mL in vial; 200 mg per 10 mL in vial; 400 mg per 20 mL in vial
    • Parenteral > General injections > SC: 162 mg per 0.9 mL in pre-filled syringe
    Indications
    Juvenile systemic arthritis
  18. Triamcinolone hexacetonide General information
    Section
    Medicines for juvenile joint diseases
    • Parenteral > Locoregional injections > Intra-articular: 20 mg per mL in vial
    Indications
    Juvenile idiopathic arthritis